-
1دورية أكاديمية
المؤلفون: Biagi M; College of Pharmacy, University of Illinois at Chicago, Chicago, IL, USA., Lee M; College of Pharmacy, University of Illinois at Chicago, Chicago, IL, USA., Wu T; College of Pharmacy, University of Illinois at Chicago, Chicago, IL, USA., Shajee A; College of Pharmacy, University of Illinois at Chicago, Rockford, IL, USA., Patel S; College of Pharmacy, University of Illinois at Chicago, Chicago, IL, USA., Deshpande LM; JMI Laboratories, North Liberty, IA, USA., Mendes RE; JMI Laboratories, North Liberty, IA, USA., Wenzler E; College of Pharmacy, University of Illinois at Chicago, Chicago, IL, USA. Electronic address: wenzler@uic.edu.
المصدر: Diagnostic microbiology and infectious disease [Diagn Microbiol Infect Dis] 2022 Jun; Vol. 103 (2), pp. 115674. Date of Electronic Publication: 2022 Mar 10.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: Elsevier Biomedical Country of Publication: United States NLM ID: 8305899 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0070 (Electronic) Linking ISSN: 07328893 NLM ISO Abbreviation: Diagn Microbiol Infect Dis Subsets: MEDLINE
-
2دورية أكاديمية
المؤلفون: Lee M; College of Pharmacy, University of Illinois at Chicago, Chicago, IL, USA., Abbey T; College of Pharmacy, University of Illinois at Chicago, Chicago, IL, USA., Biagi M; College of Pharmacy, University of Illinois at Chicago, Rockford, IL, USA., Wenzler E; College of Pharmacy, University of Illinois at Chicago, Chicago, IL, USA. Electronic address: wenzler@uic.edu.
المصدر: Diagnostic microbiology and infectious disease [Diagn Microbiol Infect Dis] 2021 Jan; Vol. 99 (1), pp. 115227. Date of Electronic Publication: 2020 Sep 28.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: Elsevier Biomedical Country of Publication: United States NLM ID: 8305899 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0070 (Electronic) Linking ISSN: 07328893 NLM ISO Abbreviation: Diagn Microbiol Infect Dis Subsets: MEDLINE
مواضيع طبية MeSH: Anti-Bacterial Agents/*therapeutic use , Azabicyclo Compounds/*therapeutic use , Ceftazidime/*therapeutic use , Pseudomonas aeruginosa/*drug effects , beta-Lactamase Inhibitors/*therapeutic use, Aztreonam/therapeutic use ; Drug Combinations ; Humans ; Microbial Sensitivity Tests ; Pseudomonas aeruginosa/metabolism ; beta-Lactamases/metabolism